Major trial tests drug to halt inherited bowel disease before it turns cancerous
Disease control
Recruiting now
This study is testing if a drug called eRapa can slow the progression of Familial Adenomatous Polyposis (FAP), an inherited condition where many polyps grow in the bowel and can turn into cancer. About 168 adults with high-risk FAP will take either eRapa or a placebo pill every o…
Phase: PHASE3 • Sponsor: Rapamycin Holdings Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC